Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.

Abstract:

:Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia with normal cytogenetics. The mutant enzyme is thought to convert α-ketoglutarate to the pathogenic 2-hydroxyglutarate (2-HG) that affects DNA methylation via inhibition of ten-eleven translocation 2. However, the role of wild-type IDH1 in normal hematopoiesis and its relevance to acute myeloid leukemia is unknown. Here we showed that zebrafish idh1 (zidh1) knockdown by morpholino and targeted mutagenesis by transcription activator-like effector nuclease might induce blockade in myeloid differentiation, as evident by an increase in pu.1 and decrease in mpo, l-plastin, and mpeg1 expression, and significantly reduce definitive hematopoiesis. Morpholino knockdown of zidh2 also induced a blockade in myeloid differentiation but definitive hematopoiesis was not affected. The hematopoietic phenotype of zidh1 knockdown was not rescuable by zidh2 messenger RNA, suggesting nonredundant functions. Overexpression of human IDH1-R132H or its zebrafish ortholog resulted in 2-HG elevation and expansion of myelopoiesis in zebrafish embryos. A human IDH1-R132H-specific inhibitor (AGI-5198) significantly ameliorated both hematopoietic and 2-HG responses in human but not zebrafish IDH1 mutant expression. The results provided important insights to the role of zidh1 in myelopoiesis and definitive hematopoiesis and of IDH1-R132H in leukemogenesis.

journal_name

Blood

journal_title

Blood

authors

Shi X,He BL,Ma AC,Guo Y,Chi Y,Man CH,Zhang W,Zhang Y,Wen Z,Cheng T,Leung AY

doi

10.1182/blood-2014-09-601187

subject

Has Abstract

pub_date

2015-05-07 00:00:00

pages

2974-84

issue

19

eissn

0006-4971

issn

1528-0020

pii

blood-2014-09-601187

journal_volume

125

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells.

    abstract::Polycythemia vera (PV) treatment with interferon α (IFNα) is frequently limited by dose-related toxicity. PV CD34(+) cells are characterized by overexpression of Bcl-xL, which can be antagonized by ABT-737 leading to apoptosis. We explored the effects of ABT-737 and IFNα on PV hematopoiesis. Both IFNα and ABT-737 alon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279125

    authors: Lu M,Wang J,Li Y,Berenzon D,Wang X,Mascarenhas J,Xu M,Hoffman R

    更新日期:2010-11-18 00:00:00

  • Glycoforms of human endothelial CD34 that bind L-selectin carry sulfated sialyl Lewis x capped O- and N-glycans.

    abstract::Endothelial sialomucin CD34 functions as an L-selectin ligand mediating lymphocyte extravasation only when properly glycosylated to express a sulfated carbohydrate epitope, 6-sulfo sialyl Lewis x (6-sulfo SLe(x)). It is thought that multivalent 6-sulfo SLe(x) expression promotes high-affinity binding to L-selectin by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-210237

    authors: Hernandez Mir G,Helin J,Skarp KP,Cummings RD,Mäkitie A,Renkonen R,Leppänen A

    更新日期:2009-07-16 00:00:00

  • Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.

    abstract::The purpose of this report was to evaluate scintigraphy analysis of Southern blot hybridization as a method to quantify the breakpoint cluster region (BCR) rearrangement of Philadelphia chromosome (Ph)+ chronic myelogenous leukemia (CML). Cytogenetic and molecular studies performed simultaneously on 474 bone marrow an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Verschraegen CF,Talpaz M,Hirsch-Ginsberg CF,Pherwani R,Rios MB,Stass SA,Kantarjian HM

    更新日期:1995-05-15 00:00:00

  • Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice.

    abstract::Deep venous thrombosis (DVT) remains a common and serious cardiovascular problem with both fatal and long-term consequences. The consequences of DVT include the development of postthrombotic syndrome in 25% to 60% of DVT patients. Despite the clinical importance of venous thrombus resolution, the cellular and molecula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-07-727180

    authors: Mukhopadhyay S,Antalis TM,Nguyen KP,Hoofnagle MH,Sarkar R

    更新日期:2017-06-15 00:00:00

  • Alteration of the erythrocyte membrane skeletal ultrastructure in hereditary spherocytosis, hereditary elliptocytosis, and pyropoikilocytosis.

    abstract::The membrane skeleton of normal erythrocytes is largely organized into a hexagonal lattice of junctional complexes (JC) crosslinked by spectrin tetramers, and occasional double tetramers and hexamers. To explore possible skeletal alterations in hereditary spherocytosis (HS), elliptocytosis (HE), and pyropoikilocytosis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Liu SC,Derick LH,Agre P,Palek J

    更新日期:1990-07-01 00:00:00

  • Chronic lymphocytic leukemia and the Warburg effect.

    abstract::In this issue of Blood, Jitschin et al demonstrate a microenvironmental glycolytic shift in chronic lymphocytic leukemia (CLL) cells mediated by Notch-c-Myc signaling. Interfering in the Notch-c-Myc pathway and reprogramming glycolytic metabolism could contribute to overcoming drug resistance in CLL. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-04-636332

    authors: Moreno C

    更新日期:2015-05-28 00:00:00

  • Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the Childrens Cancer Group.

    abstract::The prognostic significance of c-kit receptor expression on leukemic blast cells was determined in 122 children with acute myeloid leukemia (AML) entered onto Childrens Cancer Group protocol 213. Clinical and laboratory characteristics as well as outcome were analyzed according to the percentage of blast cells express...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Smith FO,Broudy VC,Zsebo KM,Lampkin BC,Buckley CV,Buckley JD,Opie T,Woods WG,Hammond GD,Bernstein ID

    更新日期:1994-08-01 00:00:00

  • Structural and functional characterization of a specific antidote for ticagrelor.

    abstract::Ticagrelor is a direct-acting reversibly binding P2Y12 antagonist and is widely used as an antiplatelet therapy for the prevention of cardiovascular events in acute coronary syndrome patients. However, antiplatelet therapy can be associated with an increased risk of bleeding. Here, we present data on the identificatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-622928

    authors: Buchanan A,Newton P,Pehrsson S,Inghardt T,Antonsson T,Svensson P,Sjögren T,Öster L,Janefeldt A,Sandinge AS,Keyes F,Austin M,Spooner J,Gennemark P,Penney M,Howells G,Vaughan T,Nylander S

    更新日期:2015-05-28 00:00:00

  • Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation.

    abstract::In lymphocytes, the second messenger cyclic adenosine monophosphate (cAMP) plays a well-established antiproliferative role through inhibition of G(1)/S transition and S-phase progression. We have previously demonstrated that, during S-phase arrest, cAMP inhibits the action of S phase-specific cytotoxic compounds, lead...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-204883

    authors: Naderi EH,Findley HW,Ruud E,Blomhoff HK,Naderi S

    更新日期:2009-07-16 00:00:00

  • Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate.

    abstract::There is considerable interest in identifying nontoxic differentiation inducers for the treatment of various malignant and nonmalignant blood disorders, including inborn beta-chain hemoglobinopathies. Using the human leukemic K562 cell line as a model, we explored the efficacy of phenylacetate, an amino acid derivativ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Samid D,Yeh A,Prasanna P

    更新日期:1992-09-15 00:00:00

  • Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha.

    abstract::In a single institution, we have used recombinant interferon- (IFN-) to treat 116 newly diagnosed Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients and analyzed the predictive factors for response and survival. The patients whose median age was 50.3 years (range, 9 to 70) were administered IFN- (5 mi...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Mahon FX,Fabères C,Pueyo S,Cony-Makhoul P,Salmi R,Boiron JM,Marit G,Bilhou-Nabera C,Carrère A,Montastruc M,Pigneux A,Bernard P,Reiffers J

    更新日期:1998-12-01 00:00:00

  • Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

    abstract::The clinical course of chronic lymphocytic leukemia (CLL) differs significantly between patients with mutated (M-CLL) and unmutated (U-CLL) immunoglobulin (Ig) variable heavy-chain (V(H)) genes, implying a role for B-cell receptor (BCR) signaling in the pathogenesis of this disease. We have now investigated activation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2669

    authors: Petlickovski A,Laurenti L,Li X,Marietti S,Chiusolo P,Sica S,Leone G,Efremov DG

    更新日期:2005-06-15 00:00:00

  • Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine.

    abstract::The activation of polymorphonuclear leukocytes (PMN) is an important step in the development of tissue damage associated with inflammatory and ischemic conditions. Catecholamines have been reported to inhibit PMN functions, but the high concentrations required cast doubt on their actual relevance as a defense mechanis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bazzoni G,Dejana E,Del Maschio A

    更新日期:1991-05-01 00:00:00

  • Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia.

    abstract::There is growing evidence that lymphocyte trafficking contributes to the clinical course of chronic lymphocytic leukemia (CLL), but to date, only static in vitro cultures have been used to study these phenomena. To address this lack of data, we have developed a dynamic in vitro model in which CLL cells experience shea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-12-544569

    authors: Walsby E,Buggins A,Devereux S,Jones C,Pratt G,Brennan P,Fegan C,Pepper C

    更新日期:2014-06-05 00:00:00

  • Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.

    abstract::The U-A10 cell line, a doxorubicin-selected variant of human U-937 myeloid leukemia cells, exhibits a redistribution of anthracyclines into a expanded vesicular compartment. The acidic nature of this compartment was confirmed by vital staining with a pH sensitive dye, LysoSensor yellow/blue DND-160. Identification of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hurwitz SJ,Terashima M,Mizunuma N,Slapak CA

    更新日期:1997-05-15 00:00:00

  • HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.

    abstract::Histone deacetylase 6 (HDAC6) is a heat shock protein 90 (hsp90) deacetylase. Treatment with pan-HDAC inhibitors or depletion of HDAC6 by siRNA induces hyperacetylation and inhibits ATP binding and chaperone function of hsp90. Treatment with 17-allylamino-demothoxy geldanamycin (17-AAG) also inhibits ATP binding and c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-143644

    authors: Rao R,Fiskus W,Yang Y,Lee P,Joshi R,Fernandez P,Mandawat A,Atadja P,Bradner JE,Bhalla K

    更新日期:2008-09-01 00:00:00

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular

    abstract::The Leukemia and Lymphoma Molecular Profiling Project recently published results from DNA microarray analyses of 240 diffuse large B-cell lymphomas (DLBCLs). Four gene expression "signatures" were identified as correlated with patient outcome, including the major histocompatibility complex (MHC) class II genes (eg, HL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2365

    authors: Rimsza LM,Roberts RA,Miller TP,Unger JM,LeBlanc M,Braziel RM,Weisenberger DD,Chan WC,Muller-Hermelink HK,Jaffe ES,Gascoyne RD,Campo E,Fuchs DA,Spier CM,Fisher RI,Delabie J,Rosenwald A,Staudt LM,Grogan TM

    更新日期:2004-06-01 00:00:00

  • Shared idiotype expression by chronic lymphocytic leukemia and B-cell lymphoma.

    abstract::Antiidiotype (Id) antibodies identify unique determinants within the surface immunoglobulin (Ig) that are present on B-cell tumors. Anti-Ids have been used for diagnosis and therapy of B-cell lymphoma and leukemia. A panel of 29 anti-Id monoclonal antibodies (MoAbs) that recognize shared idiotypes (SIds) on B-cell lym...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chatterjee M,Barcos M,Han T,Liu XL,Bernstein Z,Foon KA

    更新日期:1990-11-01 00:00:00

  • Mutations of the N-ras gene in juvenile chronic myelogenous leukemia.

    abstract::Juvenile chronic myelogenous leukemia (JCML), a myeloproliferative disorder of childhood, is distinct from adult-type chronic myelogenous leukemia (CML) and bears resemblance to chronic myelomonocytic leukemia (CMMoL). Since mutations in the N-ras gene have been found at high frequencies in CMMoL, but only rarely in C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miyauchi J,Asada M,Sasaki M,Tsunematsu Y,Kojima S,Mizutani S

    更新日期:1994-04-15 00:00:00

  • An in vitro model of erythroid egress in bone marrow.

    abstract::An in vitro system has been developed that mimics the passage of erythrocytes from the bone marrow to the circulation. Bone marrow egress and its proper regulation are vital physiologic processes. However, because of the inaccessibility of the marrow, it is difficult to evaluate the various factors important in contro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Waugh RE,Sassi M

    更新日期:1986-07-01 00:00:00

  • Use of a sensitive bioimmunoabsorbent assay to isolate and characterize monoclonal antibodies to biologically active human erythropoietin.

    abstract::At present, one of the most sensitive assays for human erythropoietin (Ep) is a bioassay that measures the Ep-dependent proliferation of spleen cells from phenylhydrazine-treated mice after 24 hours in culture. We describe how this assay can be used as the basis of a very sensitive method for detecting mouse antibodie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wognum AW,Lansdorp PM,Eaves CJ,Krystal G

    更新日期:1988-06-01 00:00:00

  • Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma.

    abstract::Active immunization with the idiotype of follicular lymphoma induces tumor-specific immunity. T cells induced in vivo by idiotype vaccination recognize human leukocyte antigen (HLA)--restricted hypervariable but not conserved idiotype peptides. We hypothesized that idiotype-directed T-cell immunity occurs naturally an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-270199

    authors: Strothmeyer AM,Papaioannou D,Dühren-von Minden M,Navarrete M,Zirlik K,Heining-Mikesch K,Veelken H

    更新日期:2010-09-09 00:00:00

  • Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein.

    abstract::Factor V (FV) deficiency is a rare bleeding disorder whose genetic basis has been described in a relatively small number of cases. Among a total of 12 genetic defects reported in severely or moderately severe deficient patients, 3 were missense mutations and in no case was the mechanism underlying the deficiency explo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1928

    authors: Duga S,Montefusco MC,Asselta R,Malcovati M,Peyvandi F,Santagostino E,Mannucci PM,Tenchini ML

    更新日期:2003-01-01 00:00:00

  • Transcription factors, translocations, and leukemia.

    abstract::The frequent occurrence of TF gene involvement in translocations associated with leukemia is remarkable, although not yet explained. The wide variety of TFs involved in these translocations and the different stages of cellular maturation argue against a unifying mechanism. Recombinases, active during B-cell and T-cell...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Nichols J,Nimer SD

    更新日期:1992-12-15 00:00:00

  • Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI.

    abstract::Mammalian erythrocytes undergo a unique maturation process in which they discard their nuclei and organelles and assume a flexible biconcave shape. We found that altered plasma lipoprotein metabolism can profoundly influence these events. Abnormal erythrocyte morphology was observed in hypercholesterolemic mice lackin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.5.1817

    authors: Holm TM,Braun A,Trigatti BL,Brugnara C,Sakamoto M,Krieger M,Andrews NC

    更新日期:2002-03-01 00:00:00

  • Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.

    abstract::Deregulation of Notch signaling has been linked to the development of T-cell leukemias and several solid malignancies. Yet, it is unknown whether Notch signaling is involved in the pathogenesis of mycosis fungoides and Sézary syndrome, the most common subtypes of cutaneous T-cell lymphoma. By immunohistochemistry of 4...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-260216

    authors: Kamstrup MR,Gjerdrum LM,Biskup E,Lauenborg BT,Ralfkiaer E,Woetmann A,Ødum N,Gniadecki R

    更新日期:2010-10-07 00:00:00

  • Proximity proteomics of endothelial Weibel-Palade bodies identifies novel regulator of von Willebrand factor secretion.

    abstract::Weibel-Palade bodies (WPB) are unique secretory organelles of endothelial cells that store factors regulating vascular hemostasis and local inflammation. Endothelial activation triggers rapid exocytosis of WPB, leading to the surface presentation of adhesion molecules relevant for leukocyte rolling (P-selectin) and pl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000786

    authors: Holthenrich A,Drexler HCA,Chehab T,Naß J,Gerke V

    更新日期:2019-09-19 00:00:00

  • Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.

    abstract::The high frequency of allogeneic reactive CD8(+) T cells in human and their resistance to immunosuppression might be one of the reasons why successful tolerance-inducing strategies in rodents have failed in primates. Studies on the requirement for T-helper cells in priming CD8(+) T-cell responses have led to disparate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268623

    authors: Lemoine R,Velge-Roussel F,Herr F,Felix R,Nivet H,Lebranchu Y,Baron C

    更新日期:2010-10-21 00:00:00

  • Thalidomide as salvage therapy for chronic graft-versus-host disease.

    abstract::Thalidomide has been reported to be an effective agent for treatment of chronic graft-versus-host disease (CGVHD). To determine the efficacy of this agent in patients with refractory CGVHD a total of 80 patients who failed to respond to prednisone (PSE) or PSE and cyclosporine (CSA) were treated with thalidomide. Sixt...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Parker PM,Chao N,Nademanee A,O'Donnell MR,Schmidt GM,Snyder DS,Stein AS,Smith EP,Molina A,Stepan DE,Kashyap A,Planas I,Spielberger R,Somlo G,Margolin K,Zwingenberger K,Wilsman K,Negrin RS,Long GD,Niland JC,Blume K

    更新日期:1995-11-01 00:00:00

  • Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia.

    abstract::Chronic lymphocytic leukemia of B-cell origin (B-CLL) is generally thought to arise by neoplastic transformation of B lymphocytes, which express CD5 and have features of an early stage of B-cell differentiation. To study isotype-switched B-CLL as a potentially more differentiated variant, we performed genetic and func...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Friedman DF,Moore JS,Erikson J,Manz J,Goldman J,Nowell PC,Silberstein LE

    更新日期:1992-11-01 00:00:00